Michael Benkowitz, President and COO of United Therapeutics Corp (UTHR), sold shares on the open market 225 times over the last year, totaling $261.2 million. His most recent sale occurred on February 23, 2026. These UTHR insider sales rank 62nd among 11,678 individuals in our database, far exceeding the average of $8.6 million per insider and 6 sales. Benkowitz made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Restricted Stock Units | 17790 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.04% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | F | Common Stock | 7837 | $536.12 | 28,625.0000 | 48,100,000 | 21.49% | 0.02% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | F | Common Stock | 6869 | $536.12 | 21,756.0000 | 48,100,000 | 24.00% | 0.01% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Restricted Stock Units | 15592 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.03% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 17790 | $0.00 | 20,500.0000 | 48,100,000 | 656.46% | 0.04% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 15592 | $0.00 | 36,462.0000 | 48,100,000 | 74.71% | 0.03% |
| March 15, 2023 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | A | Stock Options | 99720 | $0.00 | 99,720.0000 | 48,500,000 | 9999.99% | 0.21% |
| March 15, 2023 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | A | Restricted Stock Units | 15592 | $0.00 | 15,592.0000 | 48,500,000 | 9999.99% | 0.03% |
| March 15, 2023 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | A | Restricted Stock Units | 17790 | $0.00 | 17,790.0000 | 48,500,000 | 9999.99% | 0.04% |
| Feb. 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 9375 | $472.13 | 2,648.0000 | 48,100,000 | 77.98% | 0.02% |
| Feb. 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 5065 | $146.03 | 7,713.0000 | 48,100,000 | 191.28% | 0.01% |
| Feb. 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 5065 | $472.13 | 2,648.0000 | 48,100,000 | 65.67% | 0.01% |
| Feb. 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 9375 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.02% |
| Feb. 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 5065 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.01% |
| Feb. 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 9375 | $117.76 | 12,023.0000 | 48,100,000 | 354.04% | 0.02% |
| Feb. 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Feb. 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $480.75 | 2,648.0000 | 48,100,000 | 74.84% | 0.02% |
| Feb. 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $0.00 | 9,375.0000 | 48,100,000 | 60.94% | 0.03% |
| Feb. 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $0.00 | 5,065.0000 | 48,100,000 | 60.86% | 0.02% |
| Feb. 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14625 | $480.75 | 2,648.0000 | 48,100,000 | 84.67% | 0.03% |
| Feb. 17, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $117.76 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Feb. 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $0.00 | 12,940.0000 | 48,100,000 | 37.83% | 0.02% |
| Feb. 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $117.76 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Feb. 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14625 | $474.65 | 2,648.0000 | 48,100,000 | 84.67% | 0.03% |
| Feb. 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Feb. 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $474.65 | 2,648.0000 | 48,100,000 | 74.84% | 0.02% |
| Feb. 9, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $0.00 | 24,000.0000 | 48,100,000 | 37.86% | 0.03% |
| Feb. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 20,815.0000 | 48,100,000 | 27.45% | 0.02% |
| Feb. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 38,625.0000 | 48,100,000 | 27.46% | 0.03% |
| Feb. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $470.95 | 2,648.0000 | 48,100,000 | 74.84% | 0.02% |
| Feb. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Feb. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14625 | $470.95 | 2,648.0000 | 48,100,000 | 84.67% | 0.03% |
| Feb. 2, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $117.76 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 498 | $459.87 | 15,267.0000 | 48,100,000 | 3.16% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 63 | $456.87 | 10,460.0000 | 48,100,000 | 0.60% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 372 | $457.92 | 10,088.0000 | 48,100,000 | 3.56% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 377 | $458.74 | 9,711.0000 | 48,100,000 | 3.74% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 268 | $459.86 | 9,443.0000 | 48,100,000 | 2.76% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 271 | $461.12 | 9,172.0000 | 48,100,000 | 2.87% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1322 | $463.26 | 7,850.0000 | 48,100,000 | 14.41% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1225 | $464.06 | 6,625.0000 | 48,100,000 | 15.61% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 966 | $465.11 | 5,659.0000 | 48,100,000 | 14.58% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 568 | $466.06 | 5,091.0000 | 48,100,000 | 10.04% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 321 | $467.09 | 4,770.0000 | 48,100,000 | 6.31% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1573 | $468.12 | 3,197.0000 | 48,100,000 | 32.98% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 451 | $469.18 | 2,746.0000 | 48,100,000 | 14.11% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 84 | $470.37 | 2,662.0000 | 48,100,000 | 3.06% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14 | $470.76 | 2,648.0000 | 48,100,000 | 0.53% | 0.00% |
| Jan. 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $117.76 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Jan. 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14625 | $471.91 | 2,648.0000 | 48,100,000 | 84.67% | 0.03% |
| Jan. 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Jan. 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $471.91 | 2,648.0000 | 48,100,000 | 74.84% | 0.02% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 36,565.0000 | 48,100,000 | 17.72% | 0.02% |
| Jan. 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 53,250.0000 | 48,100,000 | 21.55% | 0.03% |
| Jan. 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 28,690.0000 | 48,100,000 | 21.54% | 0.02% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $117.76 | 17,273.0000 | 48,100,000 | 45.85% | 0.03% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 116 | $456.87 | 17,157.0000 | 48,100,000 | 0.67% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 692 | $457.92 | 16,465.0000 | 48,100,000 | 4.03% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 700 | $458.74 | 15,765.0000 | 48,100,000 | 4.25% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 503 | $461.12 | 14,764.0000 | 48,100,000 | 3.29% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2456 | $463.26 | 12,308.0000 | 48,100,000 | 16.64% | 0.01% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2274 | $464.06 | 10,034.0000 | 48,100,000 | 18.48% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1794 | $465.11 | 8,240.0000 | 48,100,000 | 17.88% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1055 | $466.06 | 7,185.0000 | 48,100,000 | 12.80% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 596 | $467.09 | 6,589.0000 | 48,100,000 | 8.30% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2922 | $468.12 | 3,667.0000 | 48,100,000 | 44.35% | 0.01% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 837 | $469.18 | 2,830.0000 | 48,100,000 | 22.83% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 156 | $470.37 | 2,674.0000 | 48,100,000 | 5.51% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 26 | $470.76 | 2,648.0000 | 48,100,000 | 0.97% | 0.00% |
| Jan. 20, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $0.00 | 67,875.0000 | 48,100,000 | 17.73% | 0.03% |
| Jan. 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 44,440.0000 | 48,100,000 | 15.05% | 0.02% |
| Jan. 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $117.76 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Jan. 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14625 | $479.51 | 2,648.0000 | 48,100,000 | 84.67% | 0.03% |
| Jan. 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Jan. 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $479.51 | 2,648.0000 | 48,100,000 | 74.84% | 0.02% |
| Jan. 12, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 82,500.0000 | 48,100,000 | 15.06% | 0.03% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 647 | $491.35 | 3,876.0000 | 48,100,000 | 14.30% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 598 | $492.44 | 3,278.0000 | 48,100,000 | 15.43% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 201 | $493.47 | 3,077.0000 | 48,100,000 | 6.13% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 429 | $494.27 | 2,648.0000 | 48,100,000 | 13.94% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 52,315.0000 | 48,100,000 | 13.08% | 0.02% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1169 | $485.00 | 12,180.0000 | 48,100,000 | 8.76% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 697 | $483.80 | 13,349.0000 | 48,100,000 | 4.96% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 873 | $482.72 | 14,046.0000 | 48,100,000 | 5.85% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1657 | $481.86 | 14,919.0000 | 48,100,000 | 10.00% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 697 | $480.68 | 16,576.0000 | 48,100,000 | 4.04% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $117.76 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1659 | $490.11 | 6,130.0000 | 48,100,000 | 21.30% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 677 | $489.49 | 7,789.0000 | 48,100,000 | 8.00% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1189 | $488.38 | 8,466.0000 | 48,100,000 | 12.31% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 856 | $487.40 | 9,655.0000 | 48,100,000 | 8.14% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1669 | $486.05 | 10,511.0000 | 48,100,000 | 13.70% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 893 | $490.11 | 4,523.0000 | 48,100,000 | 16.49% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 364 | $489.49 | 5,416.0000 | 48,100,000 | 6.30% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 641 | $488.38 | 5,780.0000 | 48,100,000 | 9.98% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 461 | $487.40 | 6,421.0000 | 48,100,000 | 6.70% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 899 | $486.05 | 6,882.0000 | 48,100,000 | 11.55% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 629 | $484.99 | 7,781.0000 | 48,100,000 | 7.48% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 375 | $483.80 | 8,410.0000 | 48,100,000 | 4.27% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 471 | $482.72 | 8,785.0000 | 48,100,000 | 5.09% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 891 | $481.86 | 9,256.0000 | 48,100,000 | 8.78% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 376 | $480.68 | 10,147.0000 | 48,100,000 | 3.57% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 97,125.0000 | 48,100,000 | 13.09% | 0.03% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 797 | $494.27 | 2,648.0000 | 48,100,000 | 23.13% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 374 | $493.47 | 3,445.0000 | 48,100,000 | 9.79% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1110 | $492.44 | 3,819.0000 | 48,100,000 | 22.52% | 0.00% |
| Jan. 5, 2026 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1201 | $491.35 | 4,929.0000 | 48,100,000 | 19.59% | 0.00% |
| Dec. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 60,190.0000 | 48,100,000 | 11.57% | 0.02% |
| Dec. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 111,750.0000 | 48,100,000 | 11.57% | 0.03% |
| Dec. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $502.79 | 2,648.0000 | 48,100,000 | 74.84% | 0.02% |
| Dec. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Dec. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $117.76 | 17,273.0000 | 48,100,000 | 45.85% | 0.03% |
| Dec. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14625 | $502.79 | 2,648.0000 | 48,100,000 | 84.67% | 0.03% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 6190 | $146.03 | 8,838.0000 | 48,100,000 | 233.76% | 0.01% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 126,375.0000 | 48,100,000 | 10.37% | 0.03% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 1685 | $0.00 | 68,065.0000 | 48,100,000 | 2.42% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 6190 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.01% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 80 | $518.99 | 2,648.0000 | 48,100,000 | 2.93% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 120 | $517.66 | 2,728.0000 | 48,100,000 | 4.21% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 360 | $516.36 | 2,848.0000 | 48,100,000 | 11.22% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $515.24 | 3,208.0000 | 48,100,000 | 5.87% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 6635 | $514.28 | 3,408.0000 | 48,100,000 | 66.07% | 0.01% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 360 | $512.57 | 10,043.0000 | 48,100,000 | 3.46% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 120 | $511.67 | 10,403.0000 | 48,100,000 | 1.14% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 1685 | $146.03 | 10,523.0000 | 48,100,000 | 19.07% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 80 | $518.91 | 2,648.0000 | 48,100,000 | 2.93% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $517.74 | 2,728.0000 | 48,100,000 | 6.83% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 560 | $516.37 | 2,928.0000 | 48,100,000 | 16.06% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 440 | $515.53 | 3,488.0000 | 48,100,000 | 11.20% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 11815 | $514.31 | 3,928.0000 | 48,100,000 | 75.05% | 0.02% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 848 | $513.40 | 15,743.0000 | 48,100,000 | 5.11% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 682 | $512.14 | 16,591.0000 | 48,100,000 | 3.95% | 0.00% |
| Dec. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $117.76 | 17,273.0000 | 48,100,000 | 45.85% | 0.03% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2012 | $500.31 | 2,648.0000 | 48,100,000 | 43.18% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 322 | $499.57 | 4,660.0000 | 48,100,000 | 6.46% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 777 | $495.29 | 6,640.0000 | 48,100,000 | 10.48% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 720 | $496.16 | 5,920.0000 | 48,100,000 | 10.84% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 280 | $497.42 | 5,640.0000 | 48,100,000 | 4.73% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 658 | $498.22 | 4,982.0000 | 48,100,000 | 11.67% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 779 | $494.13 | 7,417.0000 | 48,100,000 | 9.50% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1398 | $493.25 | 8,196.0000 | 48,100,000 | 14.57% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 789 | $492.31 | 9,594.0000 | 48,100,000 | 7.60% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 140 | $491.18 | 10,383.0000 | 48,100,000 | 1.33% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $478.58 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 3736 | $500.31 | 2,648.0000 | 48,100,000 | 58.52% | 0.01% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 598 | $499.57 | 6,384.0000 | 48,100,000 | 8.56% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $117.76 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1222 | $498.22 | 6,982.0000 | 48,100,000 | 14.90% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 520 | $497.42 | 8,204.0000 | 48,100,000 | 5.96% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1339 | $496.16 | 10,166.0000 | 48,100,000 | 11.64% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1442 | $495.29 | 8,724.0000 | 48,100,000 | 14.18% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1446 | $494.13 | 11,505.0000 | 48,100,000 | 11.17% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2596 | $493.25 | 12,951.0000 | 48,100,000 | 16.70% | 0.01% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1466 | $492.31 | 15,547.0000 | 48,100,000 | 8.62% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 260 | $491.18 | 17,013.0000 | 48,100,000 | 1.51% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 6,190.0000 | 48,100,000 | 55.99% | 0.02% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 141,000.0000 | 48,100,000 | 9.40% | 0.03% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 155,625.0000 | 48,100,000 | 8.59% | 0.03% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 14,065.0000 | 48,100,000 | 35.89% | 0.02% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $117.76 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14625 | $478.58 | 2,648.0000 | 48,100,000 | 84.67% | 0.03% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $478.58 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $478.58 | 2,648.0000 | 48,100,000 | 74.84% | 0.02% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1563 | $480.80 | 6,515.0000 | 48,100,000 | 19.35% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 182 | $482.69 | 5,422.0000 | 48,100,000 | 3.25% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 126 | $483.42 | 2,648.0000 | 48,100,000 | 4.54% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 170,250.0000 | 48,100,000 | 7.91% | 0.03% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $146.03 | 21,940.0000 | 48,100,000 | 26.41% | 0.02% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2904 | $480.80 | 4,911.0000 | 48,100,000 | 37.16% | 0.01% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 4545 | $479.79 | 7,815.0000 | 48,100,000 | 36.77% | 0.01% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2935 | $478.98 | 12,360.0000 | 48,100,000 | 19.19% | 0.01% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $117.76 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1978 | $477.94 | 15,295.0000 | 48,100,000 | 11.45% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1065 | $477.94 | 9,458.0000 | 48,100,000 | 10.12% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1581 | $478.98 | 7,877.0000 | 48,100,000 | 16.72% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2447 | $479.79 | 5,430.0000 | 48,100,000 | 31.07% | 0.01% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 911 | $481.63 | 5,604.0000 | 48,100,000 | 13.98% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 234 | $483.42 | 2,648.0000 | 48,100,000 | 8.12% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 338 | $482.69 | 2,882.0000 | 48,100,000 | 10.50% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1691 | $481.63 | 3,220.0000 | 48,100,000 | 34.43% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2625 | $117.76 | 5,273.0000 | 48,100,000 | 99.13% | 0.01% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2625 | $473.66 | 2,648.0000 | 48,100,000 | 49.78% | 0.01% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 12000 | $135.42 | 14,648.0000 | 48,100,000 | 453.17% | 0.02% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 12000 | $473.66 | 2,648.0000 | 48,100,000 | 81.92% | 0.02% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 29,815.0000 | 48,100,000 | 20.89% | 0.02% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $473.66 | 2,648.0000 | 48,100,000 | 74.84% | 0.02% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Option | 12000 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.02% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2625 | $0.00 | 184,875.0000 | 48,100,000 | 1.40% | 0.01% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $470.43 | 2,648.0000 | 48,100,000 | 74.84% | 0.02% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 5250 | $0.00 | 37,690.0000 | 48,100,000 | 12.23% | 0.01% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2625 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.01% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 12,000.0000 | 48,100,000 | 54.93% | 0.03% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 5250 | $146.03 | 10,523.0000 | 48,100,000 | 99.56% | 0.01% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2625 | $146.03 | 5,273.0000 | 48,100,000 | 99.13% | 0.01% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14625 | $470.43 | 2,648.0000 | 48,100,000 | 84.67% | 0.03% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $135.42 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $452.04 | 2,648.0000 | 48,100,000 | 74.84% | 0.02% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14625 | $452.09 | 2,648.0000 | 48,100,000 | 84.67% | 0.03% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $135.42 | 17,273.0000 | 48,100,000 | 45.85% | 0.03% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 2,625.0000 | 48,100,000 | 75.00% | 0.02% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 26,625.0000 | 48,100,000 | 35.45% | 0.03% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 511 | $440.71 | 2,818.0000 | 48,100,000 | 15.35% | 0.00% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 575 | $439.35 | 3,329.0000 | 48,100,000 | 14.73% | 0.00% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 585 | $438.34 | 3,904.0000 | 48,100,000 | 13.03% | 0.00% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 890 | $437.70 | 4,489.0000 | 48,100,000 | 16.55% | 0.00% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2121 | $436.45 | 5,379.0000 | 48,100,000 | 28.28% | 0.00% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 3204 | $435.52 | 7,500.0000 | 48,100,000 | 29.93% | 0.01% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2918 | $434.68 | 10,704.0000 | 48,100,000 | 21.42% | 0.01% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2687 | $433.52 | 13,622.0000 | 48,100,000 | 16.48% | 0.01% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $135.42 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 964 | $432.55 | 16,309.0000 | 48,100,000 | 5.58% | 0.00% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 10,500.0000 | 48,100,000 | 42.86% | 0.02% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 41,250.0000 | 48,100,000 | 26.17% | 0.03% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $417.50 | 2,648.0000 | 48,100,000 | 74.84% | 0.02% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Nov. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 170 | $441.94 | 2,648.0000 | 48,100,000 | 6.03% | 0.00% |
| Oct. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 1750 | $0.00 | 55,875.0000 | 48,100,000 | 3.04% | 0.00% |
| Oct. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $135.42 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Oct. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14625 | $417.50 | 2,648.0000 | 48,100,000 | 84.67% | 0.03% |
| Oct. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 6125 | $146.03 | 8,773.0000 | 48,100,000 | 231.31% | 0.01% |
| Oct. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 1750 | $146.03 | 10,523.0000 | 48,100,000 | 19.95% | 0.00% |
| Oct. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $417.50 | 2,778.0000 | 48,100,000 | 73.92% | 0.02% |
| Oct. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 55,875.0000 | 48,100,000 | 20.74% | 0.03% |
| Oct. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 6125 | $0.00 | 74,250.0000 | 48,100,000 | 7.62% | 0.01% |
| Oct. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14625 | $427.41 | 2,648.0000 | 48,100,000 | 84.67% | 0.03% |
| Oct. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Oct. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $427.41 | 2,648.0000 | 48,100,000 | 74.84% | 0.02% |
| Oct. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 72,250.0000 | 48,100,000 | 16.83% | 0.03% |
| Oct. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 72,250.0000 | 48,100,000 | 9.83% | 0.02% |
| Oct. 20, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $135.42 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Oct. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $135.42 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Oct. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 9,625.0000 | 48,100,000 | 45.00% | 0.02% |
| Oct. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 85,125.0000 | 48,100,000 | 14.66% | 0.03% |
| Oct. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $440.35 | 2,648.0000 | 48,100,000 | 74.84% | 0.02% |
| Oct. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Oct. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14625 | $440.35 | 2,648.0000 | 48,100,000 | 84.67% | 0.03% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 11975 | $452.03 | 4,098.0000 | 48,100,000 | 74.50% | 0.02% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $253.98 | 2,648.0000 | 48,100,000 | 7.02% | 0.00% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1250 | $453.16 | 2,848.0000 | 48,100,000 | 30.50% | 0.00% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,100,000 | 297.39% | 0.02% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $450.06 | 10,223.0000 | 48,100,000 | 2.85% | 0.00% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 500 | $451.01 | 9,723.0000 | 48,100,000 | 4.89% | 0.00% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 6625 | $452.04 | 3,098.0000 | 48,100,000 | 68.14% | 0.01% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 17,500.0000 | 48,100,000 | 31.03% | 0.02% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 99,750.0000 | 48,100,000 | 12.79% | 0.03% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $454.81 | 2,648.0000 | 48,100,000 | 3.64% | 0.00% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 350 | $453.51 | 2,748.0000 | 48,100,000 | 11.30% | 0.00% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $135.42 | 17,273.0000 | 48,100,000 | 552.30% | 0.03% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 400 | $449.82 | 16,873.0000 | 48,100,000 | 2.32% | 0.00% |
| Oct. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 800 | $450.97 | 16,073.0000 | 48,100,000 | 4.74% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 51 | $429.50 | 2,683.0000 | 48,500,000 | 1.87% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 114,375.0000 | 48,500,000 | 11.34% | 0.03% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 25,375.0000 | 48,500,000 | 23.68% | 0.02% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $135.42 | 17,273.0000 | 48,500,000 | 552.30% | 0.03% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 650 | $416.60 | 16,623.0000 | 48,500,000 | 3.76% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1235 | $417.52 | 15,388.0000 | 48,500,000 | 7.43% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 690 | $418.80 | 14,698.0000 | 48,500,000 | 4.48% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1327 | $419.77 | 13,371.0000 | 48,500,000 | 9.03% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1971 | $420.94 | 11,400.0000 | 48,500,000 | 14.74% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2659 | $421.75 | 8,741.0000 | 48,500,000 | 23.32% | 0.01% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2073 | $422.72 | 6,668.0000 | 48,500,000 | 23.72% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2206 | $423.93 | 4,462.0000 | 48,500,000 | 33.08% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 674 | $424.80 | 3,788.0000 | 48,500,000 | 15.11% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 490 | $425.84 | 3,298.0000 | 48,500,000 | 12.94% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 489 | $428.64 | 2,809.0000 | 48,500,000 | 14.83% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 96 | $429.50 | 2,713.0000 | 48,500,000 | 3.42% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 65 | $430.75 | 2,648.0000 | 48,500,000 | 2.40% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,500,000 | 297.39% | 0.02% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 350 | $416.60 | 10,173.0000 | 48,500,000 | 3.33% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 665 | $417.52 | 9,508.0000 | 48,500,000 | 6.54% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 371 | $418.80 | 9,137.0000 | 48,500,000 | 3.90% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 715 | $419.77 | 8,422.0000 | 48,500,000 | 7.83% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1062 | $420.94 | 7,360.0000 | 48,500,000 | 12.61% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1432 | $421.75 | 5,928.0000 | 48,500,000 | 19.46% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1116 | $422.72 | 4,812.0000 | 48,500,000 | 18.83% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1187 | $423.93 | 3,625.0000 | 48,500,000 | 24.67% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 363 | $424.80 | 3,262.0000 | 48,500,000 | 10.01% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 264 | $425.84 | 3,008.0000 | 48,500,000 | 8.07% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 264 | $428.64 | 2,744.0000 | 48,500,000 | 8.78% | 0.00% |
| Sept. 29, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 35 | $430.75 | 2,648.0000 | 48,500,000 | 1.30% | 0.00% |
| Sept. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 14625 | $416.35 | 2,648.0000 | 48,500,000 | 84.67% | 0.03% |
| Sept. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,500,000 | 297.39% | 0.02% |
| Sept. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $135.42 | 17,273.0000 | 48,500,000 | 552.30% | 0.03% |
| Sept. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7875 | $416.35 | 2,648.0000 | 48,500,000 | 74.84% | 0.02% |
| Sept. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 129,000.0000 | 48,500,000 | 10.18% | 0.03% |
| Sept. 22, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 33,250.0000 | 48,500,000 | 19.15% | 0.02% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1470 | $402.06 | 4,700.0000 | 48,500,000 | 23.82% | 0.00% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2052 | $403.00 | 2,648.0000 | 48,500,000 | 43.66% | 0.00% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,500,000 | 297.39% | 0.02% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 105 | $396.87 | 10,418.0000 | 48,500,000 | 1.00% | 0.00% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 820 | $397.96 | 9,598.0000 | 48,500,000 | 7.87% | 0.00% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 920 | $399.20 | 8,678.0000 | 48,500,000 | 9.59% | 0.00% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $135.42 | 17,273.0000 | 48,500,000 | 552.30% | 0.03% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | StockOptions | 7875 | $0.00 | 41,125.0000 | 48,500,000 | 16.07% | 0.02% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2068 | $400.86 | 4,321.0000 | 48,500,000 | 32.37% | 0.00% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 668 | $402.12 | 3,653.0000 | 48,500,000 | 15.46% | 0.00% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1005 | $403.08 | 2,648.0000 | 48,500,000 | 27.51% | 0.00% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | StockOptions | 14625 | $0.00 | 143,625.0000 | 48,500,000 | 9.24% | 0.03% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2289 | $400.24 | 6,389.0000 | 48,500,000 | 26.38% | 0.00% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 295 | $396.95 | 16,978.0000 | 48,500,000 | 1.71% | 0.00% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1380 | $398.02 | 15,598.0000 | 48,500,000 | 8.13% | 0.00% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1415 | $399.07 | 14,183.0000 | 48,500,000 | 9.07% | 0.00% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2910 | $400.09 | 11,273.0000 | 48,500,000 | 20.52% | 0.01% |
| Sept. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 5103 | $400.79 | 6,170.0000 | 48,500,000 | 45.27% | 0.01% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 3250 | $135.42 | 5,898.0000 | 48,500,000 | 122.73% | 0.01% |
| Sept. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 6125 | $0.00 | 49,000.0000 | 48,500,000 | 11.11% | 0.01% |
| Sept. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 11375 | $0.00 | 158,250.0000 | 48,500,000 | 6.71% | 0.02% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 1750 | $0.00 | 24,500.0000 | 48,500,000 | 6.67% | 0.00% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 3250 | $0.00 | 169,625.0000 | 48,500,000 | 1.88% | 0.01% |
| Sept. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 6500 | $400.08 | 2,648.0000 | 48,500,000 | 71.05% | 0.01% |
| Sept. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 4875 | $393.86 | 9,148.0000 | 48,500,000 | 34.76% | 0.01% |
| Sept. 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 11375 | $397.41 | 14,023.0000 | 48,500,000 | 429.57% | 0.02% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $396.10 | 2,648.0000 | 48,500,000 | 3.64% | 0.00% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 350 | $394.33 | 2,748.0000 | 48,500,000 | 11.30% | 0.00% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 400 | $392.51 | 3,098.0000 | 48,500,000 | 11.44% | 0.00% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 400 | $391.42 | 3,498.0000 | 48,500,000 | 10.26% | 0.00% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 500 | $390.46 | 3,898.0000 | 48,500,000 | 11.37% | 0.00% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 1750 | $146.03 | 4,398.0000 | 48,500,000 | 66.09% | 0.00% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $396.23 | 2,648.0000 | 48,500,000 | 7.02% | 0.00% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 233 | $395.03 | 2,848.0000 | 48,500,000 | 7.56% | 0.00% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $394.08 | 3,081.0000 | 48,500,000 | 8.87% | 0.00% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1100 | $392.18 | 3,381.0000 | 48,500,000 | 24.55% | 0.00% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1000 | $391.16 | 4,481.0000 | 48,500,000 | 18.24% | 0.00% |
| Sept. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 417 | $389.81 | 5,481.0000 | 48,500,000 | 7.07% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14625 | $135.42 | 17,273.0000 | 48,500,000 | 552.30% | 0.03% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 11375 | $419.63 | 5,898.0000 | 48,500,000 | 65.85% | 0.02% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 106 | $405.59 | 5,792.0000 | 48,500,000 | 1.80% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 500 | $407.34 | 5,292.0000 | 48,500,000 | 8.63% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 700 | $408.97 | 4,592.0000 | 48,500,000 | 13.23% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1144 | $409.97 | 3,448.0000 | 48,500,000 | 24.91% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 168 | $412.69 | 3,280.0000 | 48,500,000 | 4.87% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 32 | $413.39 | 3,248.0000 | 48,500,000 | 0.98% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $416.30 | 3,048.0000 | 48,500,000 | 6.16% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 328 | $418.03 | 2,720.0000 | 48,500,000 | 10.76% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 72 | $419.35 | 2,648.0000 | 48,500,000 | 2.65% | 0.00% |
| Sept. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7875 | $146.03 | 10,523.0000 | 48,500,000 | 297.39% | 0.02% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 888 | $407.26 | 9,635.0000 | 48,500,000 | 8.44% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $408.28 | 9,335.0000 | 48,500,000 | 3.11% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $410.35 | 9,235.0000 | 48,500,000 | 1.07% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 367 | $417.45 | 8,868.0000 | 48,500,000 | 3.97% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 95 | $419.61 | 8,773.0000 | 48,500,000 | 1.07% | 0.00% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 6125 | $419.63 | 2,648.0000 | 48,500,000 | 69.82% | 0.01% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14625 | $0.00 | 172,875.0000 | 48,500,000 | 7.80% | 0.03% |
| Sept. 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7875 | $0.00 | 55,125.0000 | 48,500,000 | 12.50% | 0.02% |
| March 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $322.86 | 2,748.0000 | 48,500,000 | 9.84% | 0.00% |
| March 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2000 | $0.00 | 0.0000 | 48,500,000 | 100.00% | 0.00% |
| March 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $323.99 | 2,648.0000 | 48,500,000 | 3.64% | 0.00% |
| March 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 358 | $321.62 | 3,048.0000 | 48,500,000 | 10.51% | 0.00% |
| March 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 533 | $320.57 | 3,406.0000 | 48,500,000 | 13.53% | 0.00% |
| March 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 316 | $319.35 | 3,939.0000 | 48,500,000 | 7.43% | 0.00% |
| March 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $317.11 | 4,255.0000 | 48,500,000 | 4.49% | 0.00% |
| March 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 193 | $313.93 | 4,455.0000 | 48,500,000 | 4.15% | 0.00% |
| March 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2000 | $111.00 | 4,648.0000 | 48,500,000 | 75.53% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $317.41 | 2,677.0000 | 48,500,000 | 10.08% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $318.70 | 2,577.0000 | 48,500,000 | 3.74% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Option | 7179 | $0.00 | 0.0000 | 48,500,000 | 100.00% | 0.01% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 2,000.0000 | 48,500,000 | 55.56% | 0.01% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 843 | $313.33 | 4,803.0000 | 48,500,000 | 14.93% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 250 | $311.74 | 5,646.0000 | 48,500,000 | 4.24% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 550 | $310.54 | 5,896.0000 | 48,500,000 | 8.53% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2010 | $309.69 | 6,446.0000 | 48,500,000 | 23.77% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1300 | $308.66 | 8,456.0000 | 48,500,000 | 13.33% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7179 | $111.00 | 9,756.0000 | 48,500,000 | 278.58% | 0.01% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 400 | $308.99 | 4,677.0000 | 48,500,000 | 7.88% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 137 | $318.82 | 2,577.0000 | 48,500,000 | 5.05% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 600 | $313.93 | 2,977.0000 | 48,500,000 | 16.77% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 363 | $317.93 | 2,714.0000 | 48,500,000 | 11.80% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 578 | $316.97 | 3,077.0000 | 48,500,000 | 15.81% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 122 | $315.49 | 3,655.0000 | 48,500,000 | 3.23% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $311.01 | 3,577.0000 | 48,500,000 | 7.74% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 800 | $309.82 | 3,877.0000 | 48,500,000 | 17.10% | 0.00% |
| March 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1026 | $313.98 | 3,777.0000 | 48,500,000 | 21.36% | 0.00% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $359.77 | 4,114.0000 | 48,500,000 | 4.64% | 0.00% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 496 | $362.29 | 2,777.0000 | 48,500,000 | 15.15% | 0.00% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $363.48 | 2,577.0000 | 48,500,000 | 7.20% | 0.00% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Option | 7500 | $0.00 | 7,179.0000 | 48,500,000 | 51.09% | 0.02% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 4,500.0000 | 48,500,000 | 35.71% | 0.01% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7500 | $111.00 | 10,077.0000 | 48,500,000 | 291.04% | 0.02% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1479 | $358.67 | 8,598.0000 | 48,500,000 | 14.68% | 0.00% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1598 | $359.88 | 7,000.0000 | 48,500,000 | 18.59% | 0.00% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1520 | $360.72 | 5,480.0000 | 48,500,000 | 21.71% | 0.00% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2100 | $361.87 | 3,380.0000 | 48,500,000 | 38.32% | 0.00% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 403 | $362.79 | 2,977.0000 | 48,500,000 | 11.92% | 0.00% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 400 | $364.27 | 2,577.0000 | 48,500,000 | 13.44% | 0.00% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 763 | $358.85 | 4,314.0000 | 48,500,000 | 15.03% | 0.00% |
| Feb. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 841 | $361.13 | 3,273.0000 | 48,500,000 | 20.44% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 499 | $372.82 | 2,677.0000 | 48,500,000 | 15.71% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7500 | $111.00 | 10,077.0000 | 48,500,000 | 291.04% | 0.02% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $366.19 | 9,977.0000 | 48,500,000 | 0.99% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 600 | $368.32 | 9,377.0000 | 48,500,000 | 6.01% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1432 | $369.65 | 7,945.0000 | 48,500,000 | 15.27% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1068 | $370.70 | 6,877.0000 | 48,500,000 | 13.44% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2351 | $371.47 | 4,526.0000 | 48,500,000 | 34.19% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1549 | $372.63 | 2,977.0000 | 48,500,000 | 34.22% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 400 | $373.67 | 2,577.0000 | 48,500,000 | 13.44% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $367.97 | 4,877.0000 | 48,500,000 | 3.94% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 500 | $369.43 | 4,377.0000 | 48,500,000 | 10.25% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 601 | $370.85 | 3,776.0000 | 48,500,000 | 13.73% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 600 | $371.67 | 3,176.0000 | 48,500,000 | 15.89% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $374.18 | 2,577.0000 | 48,500,000 | 3.74% | 0.00% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Option | 7500 | $0.00 | 14,679.0000 | 48,500,000 | 33.82% | 0.02% |
| Feb. 18, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 7,000.0000 | 48,500,000 | 26.32% | 0.01% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 720 | $349.90 | 2,622.0000 | 48,500,000 | 21.54% | 0.00% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1696 | $349.10 | 3,342.0000 | 48,500,000 | 33.66% | 0.00% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 3697 | $347.98 | 5,038.0000 | 48,500,000 | 42.32% | 0.01% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7500 | $0.00 | 22,179.0000 | 48,500,000 | 25.27% | 0.02% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Option | 2500 | $0.00 | 9,500.0000 | 48,500,000 | 20.83% | 0.01% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $350.18 | 2,577.0000 | 48,500,000 | 3.74% | 0.00% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 45 | $352.43 | 2,577.0000 | 48,500,000 | 1.72% | 0.00% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 500 | $345.90 | 4,577.0000 | 48,500,000 | 9.85% | 0.00% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $346.53 | 8,735.0000 | 48,500,000 | 2.24% | 0.00% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1200 | $348.12 | 3,377.0000 | 48,500,000 | 26.22% | 0.00% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 700 | $349.30 | 2,677.0000 | 48,500,000 | 20.73% | 0.00% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1142 | $345.69 | 8,935.0000 | 48,500,000 | 11.33% | 0.00% |
| Feb. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7500 | $111.00 | 10,077.0000 | 48,500,000 | 291.04% | 0.02% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 500 | $353.30 | 6,586.0000 | 48,500,000 | 7.06% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7500 | $111.00 | 10,077.0000 | 48,500,000 | 291.04% | 0.02% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 600 | $347.32 | 9,477.0000 | 48,500,000 | 5.95% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $348.64 | 9,277.0000 | 48,500,000 | 2.11% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 418 | $350.37 | 8,859.0000 | 48,500,000 | 4.51% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 652 | $351.32 | 8,207.0000 | 48,500,000 | 7.36% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1121 | $352.37 | 7,086.0000 | 48,500,000 | 13.66% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1005 | $354.80 | 5,581.0000 | 48,500,000 | 15.26% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1204 | $355.63 | 4,377.0000 | 48,500,000 | 21.57% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1600 | $356.81 | 2,777.0000 | 48,500,000 | 36.55% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $358.08 | 2,577.0000 | 48,500,000 | 7.20% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $347.05 | 4,877.0000 | 48,500,000 | 3.94% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $348.61 | 4,777.0000 | 48,500,000 | 2.05% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $350.05 | 4,677.0000 | 48,500,000 | 2.09% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 400 | $351.79 | 4,277.0000 | 48,500,000 | 8.55% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 400 | $353.13 | 3,877.0000 | 48,500,000 | 9.35% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 400 | $354.69 | 3,477.0000 | 48,500,000 | 10.32% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 400 | $355.58 | 3,077.0000 | 48,500,000 | 11.50% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 500 | $357.01 | 2,577.0000 | 48,500,000 | 16.25% | 0.00% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Option | 2500 | $0.00 | 12,000.0000 | 48,500,000 | 17.24% | 0.01% |
| Feb. 3, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7500 | $0.00 | 29,679.0000 | 48,500,000 | 20.17% | 0.02% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $373.99 | 2,577.0000 | 48,500,000 | 7.20% | 0.00% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 500 | $372.66 | 2,777.0000 | 48,500,000 | 15.26% | 0.00% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 405 | $371.09 | 3,277.0000 | 48,500,000 | 11.00% | 0.00% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1395 | $369.70 | 3,682.0000 | 48,500,000 | 27.48% | 0.00% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $375.22 | 2,577.0000 | 48,500,000 | 3.74% | 0.00% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 700 | $373.62 | 2,677.0000 | 48,500,000 | 20.73% | 0.00% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1000 | $372.41 | 3,377.0000 | 48,500,000 | 22.85% | 0.00% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 544 | $371.52 | 4,377.0000 | 48,500,000 | 11.05% | 0.00% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1009 | $370.54 | 4,921.0000 | 48,500,000 | 17.02% | 0.00% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 4147 | $369.54 | 5,930.0000 | 48,500,000 | 41.15% | 0.01% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7500 | $111.00 | 10,077.0000 | 48,500,000 | 291.04% | 0.02% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 14,500.0000 | 48,500,000 | 14.71% | 0.01% |
| Jan. 27, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7500 | $0.00 | 37,179.0000 | 48,500,000 | 16.79% | 0.02% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 245 | $368.08 | 2,577.0000 | 48,500,000 | 8.68% | 0.00% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 17,000.0000 | 48,500,000 | 12.82% | 0.01% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7500 | $0.00 | 44,679.0000 | 48,500,000 | 14.37% | 0.02% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7500 | $111.00 | 10,077.0000 | 48,500,000 | 291.04% | 0.02% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1860 | $362.71 | 8,217.0000 | 48,500,000 | 18.46% | 0.00% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1140 | $363.41 | 7,077.0000 | 48,500,000 | 13.87% | 0.00% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 800 | $364.84 | 6,277.0000 | 48,500,000 | 11.30% | 0.00% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2000 | $365.95 | 4,277.0000 | 48,500,000 | 31.86% | 0.00% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1199 | $366.68 | 3,078.0000 | 48,500,000 | 28.03% | 0.00% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 401 | $368.08 | 2,677.0000 | 48,500,000 | 13.03% | 0.00% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $369.19 | 2,577.0000 | 48,500,000 | 3.74% | 0.00% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 900 | $362.88 | 4,177.0000 | 48,500,000 | 17.73% | 0.00% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $364.44 | 3,877.0000 | 48,500,000 | 7.18% | 0.00% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 619 | $365.60 | 3,258.0000 | 48,500,000 | 15.97% | 0.00% |
| Jan. 21, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 436 | $366.57 | 2,822.0000 | 48,500,000 | 13.38% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1432 | $366.87 | 3,177.0000 | 48,500,000 | 31.07% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7500 | $111.00 | 10,077.0000 | 48,500,000 | 291.04% | 0.02% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 196 | $360.85 | 9,881.0000 | 48,500,000 | 1.95% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 604 | $361.95 | 9,277.0000 | 48,500,000 | 6.11% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1668 | $362.67 | 7,609.0000 | 48,500,000 | 17.98% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1300 | $363.80 | 6,309.0000 | 48,500,000 | 17.09% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 800 | $364.90 | 5,509.0000 | 48,500,000 | 12.68% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 900 | $365.79 | 4,609.0000 | 48,500,000 | 16.34% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 600 | $367.89 | 2,577.0000 | 48,500,000 | 18.89% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 775 | $362.58 | 4,302.0000 | 48,500,000 | 15.26% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 600 | $364.06 | 3,702.0000 | 48,500,000 | 13.95% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 425 | $365.58 | 3,277.0000 | 48,500,000 | 11.48% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 600 | $366.98 | 2,677.0000 | 48,500,000 | 18.31% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $367.99 | 2,577.0000 | 48,500,000 | 3.74% | 0.00% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7500 | $0.00 | 52,179.0000 | 48,500,000 | 12.57% | 0.02% |
| Jan. 13, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 19,500.0000 | 48,500,000 | 11.36% | 0.01% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 22,000.0000 | 48,500,000 | 10.20% | 0.01% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7500 | $111.00 | 10,077.0000 | 48,500,000 | 291.04% | 0.02% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1022 | $353.60 | 9,055.0000 | 48,500,000 | 10.14% | 0.00% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 3620 | $354.59 | 5,435.0000 | 48,500,000 | 39.98% | 0.01% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1458 | $355.30 | 3,977.0000 | 48,500,000 | 26.83% | 0.00% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 419 | $356.61 | 3,558.0000 | 48,500,000 | 10.54% | 0.00% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7500 | $0.00 | 59,679.0000 | 48,500,000 | 11.16% | 0.02% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 681 | $357.54 | 2,877.0000 | 48,500,000 | 19.14% | 0.00% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $358.32 | 2,577.0000 | 48,500,000 | 10.43% | 0.00% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 700 | $353.91 | 4,377.0000 | 48,500,000 | 13.79% | 0.00% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1180 | $355.04 | 3,197.0000 | 48,500,000 | 26.96% | 0.00% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $355.79 | 2,997.0000 | 48,500,000 | 6.26% | 0.00% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 220 | $357.26 | 2,777.0000 | 48,500,000 | 7.34% | 0.00% |
| Jan. 6, 2025 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $358.30 | 2,577.0000 | 48,500,000 | 7.20% | 0.00% |
| Dec. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7500 | $111.00 | 10,077.0000 | 48,500,000 | 291.04% | 0.02% |
| Dec. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1318 | $355.46 | 8,759.0000 | 48,500,000 | 13.08% | 0.00% |
| Dec. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 3025 | $356.38 | 5,734.0000 | 48,500,000 | 34.54% | 0.01% |
| Dec. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2757 | $357.28 | 2,977.0000 | 48,500,000 | 48.08% | 0.01% |
| Dec. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 400 | $358.18 | 2,577.0000 | 48,500,000 | 13.44% | 0.00% |
| Dec. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Dec. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 500 | $355.69 | 4,577.0000 | 48,500,000 | 9.85% | 0.00% |
| Dec. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 820 | $356.51 | 3,757.0000 | 48,500,000 | 17.92% | 0.00% |
| Dec. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1080 | $357.37 | 2,677.0000 | 48,500,000 | 28.75% | 0.00% |
| Dec. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $358.17 | 2,577.0000 | 48,500,000 | 3.74% | 0.00% |
| Dec. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 24,500.0000 | 48,500,000 | 9.26% | 0.01% |
| Dec. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7500 | $0.00 | 67,179.0000 | 48,500,000 | 10.04% | 0.02% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7500 | $0.00 | 74,679.0000 | 48,500,000 | 9.13% | 0.02% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7500 | $111.00 | 10,077.0000 | 48,500,000 | 291.04% | 0.02% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $356.17 | 9,977.0000 | 48,500,000 | 0.99% | 0.00% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 604 | $358.56 | 9,373.0000 | 48,500,000 | 6.05% | 0.00% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 352 | $360.29 | 9,021.0000 | 48,500,000 | 3.76% | 0.00% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1148 | $361.16 | 7,873.0000 | 48,500,000 | 12.73% | 0.00% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2700 | $362.02 | 5,173.0000 | 48,500,000 | 34.29% | 0.01% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1496 | $363.09 | 3,677.0000 | 48,500,000 | 28.92% | 0.00% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1100 | $363.87 | 2,577.0000 | 48,500,000 | 29.92% | 0.00% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $358.71 | 4,777.0000 | 48,500,000 | 5.91% | 0.00% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $360.52 | 4,677.0000 | 48,500,000 | 2.09% | 0.00% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1300 | $362.06 | 3,377.0000 | 48,500,000 | 27.80% | 0.00% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 600 | $363.15 | 2,777.0000 | 48,500,000 | 17.77% | 0.00% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $363.95 | 2,577.0000 | 48,500,000 | 7.20% | 0.00% |
| Dec. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 27,000.0000 | 48,500,000 | 8.47% | 0.01% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 500 | $372.15 | 2,577.0000 | 48,500,000 | 16.25% | 0.00% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 3352 | $111.00 | 5,929.0000 | 48,500,000 | 130.07% | 0.01% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 4148 | $111.00 | 10,077.0000 | 48,500,000 | 69.96% | 0.01% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $363.25 | 9,977.0000 | 48,500,000 | 0.99% | 0.00% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $364.97 | 9,877.0000 | 48,500,000 | 1.00% | 0.00% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 768 | $367.70 | 9,109.0000 | 48,500,000 | 7.78% | 0.00% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1336 | $368.94 | 7,773.0000 | 48,500,000 | 14.67% | 0.00% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1510 | $369.90 | 6,263.0000 | 48,500,000 | 19.43% | 0.00% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1981 | $370.96 | 4,282.0000 | 48,500,000 | 31.63% | 0.00% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1644 | $372.18 | 2,638.0000 | 48,500,000 | 38.39% | 0.00% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 61 | $372.60 | 2,577.0000 | 48,500,000 | 2.31% | 0.00% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $363.25 | 4,977.0000 | 48,500,000 | 1.97% | 0.00% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $368.16 | 4,677.0000 | 48,500,000 | 6.03% | 0.00% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 800 | $369.57 | 3,877.0000 | 48,500,000 | 17.10% | 0.00% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 800 | $370.93 | 3,077.0000 | 48,500,000 | 20.63% | 0.00% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 3352 | $0.00 | 82,179.0000 | 48,500,000 | 3.92% | 0.01% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 4148 | $0.00 | 0.0000 | 48,500,000 | 100.00% | 0.01% |
| Dec. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 29,500.0000 | 48,500,000 | 7.81% | 0.01% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 32,000.0000 | 48,500,000 | 7.25% | 0.01% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 4500 | $102.11 | 7,077.0000 | 48,500,000 | 174.62% | 0.01% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 3000 | $111.00 | 5,577.0000 | 48,500,000 | 116.41% | 0.01% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 926 | $366.27 | 8,936.0000 | 48,500,000 | 9.39% | 0.00% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2700 | $368.28 | 2,755.0000 | 48,500,000 | 49.50% | 0.01% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $370.75 | 2,655.0000 | 48,500,000 | 3.63% | 0.00% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 3481 | $367.54 | 5,455.0000 | 48,500,000 | 38.95% | 0.01% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 78 | $372.39 | 2,577.0000 | 48,500,000 | 2.94% | 0.00% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $364.87 | 4,977.0000 | 48,500,000 | 1.97% | 0.00% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 393 | $366.58 | 4,584.0000 | 48,500,000 | 7.90% | 0.00% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1300 | $367.73 | 3,284.0000 | 48,500,000 | 28.36% | 0.00% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 607 | $368.47 | 2,677.0000 | 48,500,000 | 18.48% | 0.00% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $370.75 | 2,577.0000 | 48,500,000 | 3.74% | 0.00% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 215 | $364.92 | 9,862.0000 | 48,500,000 | 2.13% | 0.00% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 4500 | $0.00 | 0.0000 | 48,500,000 | 100.00% | 0.01% |
| Dec. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 3000 | $0.00 | 4,148.0000 | 48,500,000 | 41.97% | 0.01% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7500 | $102.11 | 10,077.0000 | 48,500,000 | 291.04% | 0.02% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 34,500.0000 | 48,500,000 | 6.76% | 0.01% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7500 | $0.00 | 4,500.0000 | 48,500,000 | 62.50% | 0.02% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $374.48 | 2,577.0000 | 48,500,000 | 3.74% | 0.00% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $372.37 | 2,677.0000 | 48,500,000 | 3.60% | 0.00% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 600 | $371.50 | 2,777.0000 | 48,500,000 | 17.77% | 0.00% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1194 | $370.43 | 3,377.0000 | 48,500,000 | 26.12% | 0.00% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 506 | $369.52 | 4,571.0000 | 48,500,000 | 9.97% | 0.00% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $374.46 | 2,577.0000 | 48,500,000 | 3.74% | 0.00% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 400 | $372.37 | 2,677.0000 | 48,500,000 | 13.00% | 0.00% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1162 | $371.42 | 2,977.0000 | 48,500,000 | 28.07% | 0.00% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 3859 | $370.38 | 4,239.0000 | 48,500,000 | 47.65% | 0.01% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1779 | $369.50 | 8,098.0000 | 48,500,000 | 18.01% | 0.00% |
| Dec. 2, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $368.01 | 9,877.0000 | 48,500,000 | 1.98% | 0.00% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 37,000.0000 | 48,500,000 | 6.33% | 0.01% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7500 | $102.11 | 10,077.0000 | 48,500,000 | 291.04% | 0.02% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 398 | $368.76 | 9,679.0000 | 48,500,000 | 3.95% | 0.00% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 500 | $369.46 | 9,179.0000 | 48,500,000 | 5.17% | 0.00% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $371.15 | 8,879.0000 | 48,500,000 | 3.27% | 0.00% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1455 | $372.20 | 7,424.0000 | 48,500,000 | 16.39% | 0.00% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 3208 | $373.17 | 4,216.0000 | 48,500,000 | 43.21% | 0.01% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1116 | $374.15 | 3,100.0000 | 48,500,000 | 26.47% | 0.00% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 423 | $375.07 | 2,677.0000 | 48,500,000 | 13.65% | 0.00% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $376.18 | 2,577.0000 | 48,500,000 | 3.74% | 0.00% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 284 | $368.84 | 4,793.0000 | 48,500,000 | 5.59% | 0.00% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 532 | $372.09 | 4,261.0000 | 48,500,000 | 11.10% | 0.00% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1082 | $373.39 | 3,179.0000 | 48,500,000 | 25.39% | 0.00% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 402 | $374.35 | 2,777.0000 | 48,500,000 | 12.65% | 0.00% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $375.12 | 2,577.0000 | 48,500,000 | 7.20% | 0.00% |
| Nov. 25, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7500 | $0.00 | 12,000.0000 | 48,500,000 | 38.46% | 0.02% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 7500 | $0.00 | 19,500.0000 | 48,500,000 | 27.78% | 0.02% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 7500 | $102.11 | 7,500.0000 | 48,500,000 | 9999.99% | 0.02% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 901 | $357.03 | 6,599.0000 | 48,500,000 | 12.01% | 0.00% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1099 | $358.00 | 5,500.0000 | 48,500,000 | 16.65% | 0.00% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2921 | $359.01 | 2,579.0000 | 48,500,000 | 53.11% | 0.01% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1443 | $360.31 | 1,136.0000 | 48,500,000 | 55.95% | 0.00% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 899 | $361.20 | 237.0000 | 48,500,000 | 79.14% | 0.00% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 237 | $362.02 | 0.0000 | 48,500,000 | 100.00% | 0.00% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 2,500.0000 | 48,500,000 | 9999.99% | 0.01% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $356.42 | 2,300.0000 | 48,500,000 | 8.00% | 0.00% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 447 | $357.79 | 1,853.0000 | 48,500,000 | 19.43% | 0.00% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 846 | $358.89 | 1,007.0000 | 48,500,000 | 45.66% | 0.00% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 500 | $359.64 | 507.0000 | 48,500,000 | 49.65% | 0.00% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 307 | $360.95 | 200.0000 | 48,500,000 | 60.55% | 0.00% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $361.86 | 0.0000 | 48,500,000 | 100.00% | 0.00% |
| Nov. 18, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 39,500.0000 | 48,500,000 | 5.95% | 0.01% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1670 | $409.06 | 3,329.0000 | 48,500,000 | 33.41% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 11250 | $102.11 | 11,250.0000 | 48,500,000 | 9999.99% | 0.02% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 741 | $401.02 | 10,509.0000 | 48,500,000 | 6.59% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 456 | $402.47 | 10,053.0000 | 48,500,000 | 4.34% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1361 | $403.31 | 8,692.0000 | 48,500,000 | 13.54% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1142 | $404.31 | 7,550.0000 | 48,500,000 | 13.14% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 742 | $405.37 | 6,808.0000 | 48,500,000 | 9.83% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 428 | $406.56 | 6,380.0000 | 48,500,000 | 6.29% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1381 | $407.77 | 4,999.0000 | 48,500,000 | 21.65% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 3030 | $410.54 | 299.0000 | 48,500,000 | 91.02% | 0.01% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 216 | $410.86 | 83.0000 | 48,500,000 | 72.24% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 83 | $412.25 | 0.0000 | 48,500,000 | 100.00% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 3750 | $111.00 | 3,750.0000 | 48,500,000 | 9999.99% | 0.01% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 426 | $405.20 | 3,324.0000 | 48,500,000 | 11.36% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 89 | $406.63 | 3,235.0000 | 48,500,000 | 2.68% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1294 | $407.82 | 1,941.0000 | 48,500,000 | 40.00% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1451 | $408.77 | 490.0000 | 48,500,000 | 74.76% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 284 | $409.26 | 206.0000 | 48,500,000 | 57.96% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 106 | $410.29 | 100.0000 | 48,500,000 | 51.46% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 84 | $411.63 | 16.0000 | 48,500,000 | 84.00% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 16 | $412.64 | 0.0000 | 48,500,000 | 100.00% | 0.00% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 11250 | $0.00 | 27,000.0000 | 48,500,000 | 29.41% | 0.02% |
| Nov. 11, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 3750 | $0.00 | 42,000.0000 | 48,500,000 | 8.20% | 0.01% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $394.25 | 3,700.0000 | 48,500,000 | 7.50% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 4500 | $120.26 | 7,077.0000 | 48,500,000 | 174.62% | 0.01% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 3000 | $102.11 | 10,077.0000 | 48,500,000 | 42.39% | 0.01% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 800 | $391.70 | 9,277.0000 | 48,500,000 | 7.94% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1592 | $392.77 | 7,685.0000 | 48,500,000 | 17.16% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1507 | $393.94 | 6,178.0000 | 48,500,000 | 19.61% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 204 | $395.28 | 5,974.0000 | 48,500,000 | 3.30% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1100 | $396.16 | 4,874.0000 | 48,500,000 | 18.41% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 972 | $397.16 | 3,902.0000 | 48,500,000 | 19.94% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1025 | $397.99 | 2,877.0000 | 48,500,000 | 26.27% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $398.90 | 2,577.0000 | 48,500,000 | 10.43% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 2500 | $111.00 | 5,077.0000 | 48,500,000 | 97.01% | 0.01% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 777 | $392.36 | 4,300.0000 | 48,500,000 | 15.30% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 300 | $393.42 | 4,000.0000 | 48,500,000 | 6.98% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 530 | $396.55 | 3,170.0000 | 48,500,000 | 14.32% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 493 | $397.60 | 2,677.0000 | 48,500,000 | 15.55% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $398.62 | 2,577.0000 | 48,500,000 | 3.74% | 0.00% |
| Nov. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 11250 | $102.11 | 13,827.0000 | 48,500,000 | 436.55% | 0.02% |
| Nov. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2304 | $400.39 | 11,523.0000 | 48,500,000 | 16.66% | 0.00% |
| Nov. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 5702 | $401.55 | 5,821.0000 | 48,500,000 | 49.48% | 0.01% |
| Nov. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2640 | $402.40 | 3,181.0000 | 48,500,000 | 45.35% | 0.01% |
| Nov. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 604 | $403.14 | 2,577.0000 | 48,500,000 | 18.99% | 0.00% |
| Nov. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 3750 | $111.00 | 6,327.0000 | 48,500,000 | 145.52% | 0.01% |
| Nov. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1895 | $400.30 | 4,432.0000 | 48,500,000 | 29.95% | 0.00% |
| Nov. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1855 | $401.65 | 2,577.0000 | 48,500,000 | 41.85% | 0.00% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 4500 | $0.00 | 0.0000 | 48,500,000 | 100.00% | 0.01% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 3000 | $0.00 | 49,500.0000 | 48,500,000 | 5.71% | 0.01% |
| Nov. 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 2500 | $0.00 | 49,500.0000 | 48,500,000 | 4.81% | 0.01% |
| Nov. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 11250 | $0.00 | 38,250.0000 | 48,500,000 | 22.73% | 0.02% |
| Nov. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 3750 | $0.00 | 45,750.0000 | 48,500,000 | 7.58% | 0.01% |
| Nov. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 14700 | $0.00 | 4,500.0000 | 48,500,000 | 76.56% | 0.03% |
| Nov. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 14700 | $120.26 | 17,277.0000 | 48,500,000 | 570.43% | 0.03% |
| Nov. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $370.65 | 17,077.0000 | 48,500,000 | 1.16% | 0.00% |
| Nov. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 800 | $371.71 | 16,277.0000 | 48,500,000 | 4.68% | 0.00% |
| Nov. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1200 | $373.05 | 15,077.0000 | 48,500,000 | 7.37% | 0.00% |
| Nov. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 6096 | $374.02 | 8,981.0000 | 48,500,000 | 40.43% | 0.01% |
| Nov. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 3501 | $375.06 | 5,480.0000 | 48,500,000 | 38.98% | 0.01% |
| Nov. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1803 | $375.83 | 3,677.0000 | 48,500,000 | 32.90% | 0.00% |
| Nov. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1000 | $376.94 | 2,677.0000 | 48,500,000 | 27.20% | 0.00% |
| Nov. 1, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 100 | $378.00 | 2,577.0000 | 48,500,000 | 3.74% | 0.00% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 20000 | $0.00 | 19,200.0000 | 49,700,000 | 51.02% | 0.04% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1600 | $325.96 | 2,777.0000 | 49,700,000 | 36.55% | 0.00% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 200 | $326.92 | 2,577.0000 | 49,700,000 | 7.20% | 0.00% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Stock Options | 5000 | $0.00 | 52,000.0000 | 49,700,000 | 8.77% | 0.01% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 5000 | $111.00 | 7,577.0000 | 49,700,000 | 194.02% | 0.01% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1500 | $322.23 | 6,077.0000 | 49,700,000 | 19.80% | 0.00% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 2000 | $323.24 | 4,077.0000 | 49,700,000 | 32.91% | 0.00% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 1000 | $324.18 | 3,077.0000 | 49,700,000 | 24.53% | 0.00% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 500 | $326.01 | 2,577.0000 | 49,700,000 | 16.25% | 0.00% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 20000 | $120.26 | 22,577.0000 | 49,700,000 | 776.10% | 0.04% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 3063 | $321.95 | 19,514.0000 | 49,700,000 | 13.57% | 0.01% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7300 | $322.79 | 12,214.0000 | 49,700,000 | 37.41% | 0.01% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 7237 | $323.78 | 4,977.0000 | 49,700,000 | 59.25% | 0.01% |
| Aug. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | S | Common Stock | 600 | $324.65 | 4,377.0000 | 49,700,000 | 12.06% | 0.00% |
| May 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | D | Common Stock | 32200 | $260.51 | 2,577.0000 | 49,700,000 | 92.59% | 0.06% |
| May 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Share Tracking Award | 32200 | $0.00 | 0.0000 | 49,700,000 | 100.00% | 0.06% |
| May 6, 2024 | UNITED THERAPEUTICS Corp | $UTHR | BENKOWITZ MICHAEL | PRESIDENT AND COO | M | Common Stock | 32200 | $163.30 | 34,777.0000 | 49,700,000 | 1249.52% | 0.06% |